unmet treatment needs in subgroups of patients with multiple myeloma
Published 1 month ago • 52 plays • Length 3:54Download video MP4
Download video MP3
Similar videos
-
1:26
next-generation diagnostic and prognostic approaches in multiple myeloma
-
4:48
unmet needs in unfit/frail patients with multiple myeloma
-
1:23
unmet clinical needs in multiple myeloma
-
0:51
key unmet needs in the treatment of immune-mediated ttp
-
3:25
unmet needs and unanswered questions in multiple myeloma
-
12:26
treating ultra high risk myeloma patients in a unique uk study | martin kaiser, md | ash 2021
-
11:43
ngf in bone marrow vs qip-mass spectrometry in peripheral blood to assess mrd in ndmm pts
-
6:34
the importance of genetic testing in high-risk multiple myeloma & targeted therapy
-
0:44
unmet needs in aml: tp53 mutations and maintenance therapy
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
2:50
unmet needs in amyloidosis
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
0:45
unmet needs that remain for patients with al amyloidosis who fail frontline treatment
-
1:25
predictors and outcomes of extramedullary disease in multiple myeloma
-
1:13
the unmet needs and future of cmml treatment
-
1:53
the future of multiple myeloma treatment
-
2:44
myeloma qol through induction and maintenance
-
2:46
managing patients with high-risk myeloma
-
0:52
the unmet needs that remain for patients with systemic mastocytosis
-
2:11
unmet needs in bone marrow failure syndromes & myeloid malignancies: characterization & novel agents
-
1:48
unmet needs in hemoglobinopathy care